WS04.4 Guidance on the use of sputum biomarkers to monitor treatment response and act as trial outcomes in cystic fibrosis
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI